GENFIT (EPA:GNFT) | WebDisclosure

Basculer en Français

9479	Companies
185510	Keywords
117899	Articles
99364	Press releases

Home
Companies
GENFIT

PRESS RELEASE

published on 05/05/2025 at 07:30, 7 months ago

GENFIT présentera ses dernières avancées dans l'ACLF à l’EASL Congress 2025
GENFIT présentera ses dernières avancées dans l'ACLF au Congrès EASL 2025, avec six posters et plusieurs événements mettant en avant l'importance croissante de l'ACLF

GENFIT ACLF Patients Congrès EASL Avancées
BRIEF

published on 04/29/2025 at 21:15, 7 months 5 days ago

GENFIT Publie ses Rapports Annuels 2024

Biopharmaceutique Rapport Annuel GENFIT Document D’enregistrement Maladies Du Foie
BRIEF

published on 04/29/2025 at 21:15, 7 months 5 days ago

GENFIT Publishes its 2024 Annual Reports

Annual Report Biopharmaceuticals Registration Document Liver Diseases GENFIT
PRESS RELEASE

published on 04/29/2025 at 21:10, 7 months 5 days ago

GENFIT : Mise à disposition du Document d’Enregistrement Universel 2024 et du Rapport Annuel Form 20-F 2024
GENFIT annonce la mise à disposition du Document d’Enregistrement Universel 2024 et du Rapport Annuel Form 20-F 2024. Les rapports sont disponibles gratuitement en ligne

AMF SEC Rapport Annuel Document D’enregistrement Universel GENFIT
PRESS RELEASE

published on 04/29/2025 at 21:10, 7 months 5 days ago

GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F
GENFIT announces filing of 2024 Universal Registration Document and Annual Report on Form 20-F with AMF and SEC, available for public viewing and download. Details of reports and company's focus on liver disease research and development highlighted

2024 Universal Registration Document Form 20-F Liver Diseases GENFIT
BRIEF

published on 04/28/2025 at 22:15, 7 months 6 days ago

GENFIT's Positive Phase 2 Results for Elafibranor in PSC Announced

GENFIT Phase 2 Results Elafibranor PSC EASL Congress 2025
BRIEF

published on 04/28/2025 at 22:15, 7 months 6 days ago

Annonce des résultats positifs de phase 2 de GENFIT pour Elafibranor dans le PSC

GENFIT Résultats De La Phase 2 Elafibranor PSC Congrès EASL 2025
PRESS RELEASE

published on 04/28/2025 at 22:10, 7 months 6 days ago

GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025
GENFIT announces positive Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented at EASL Congress 2025 by Ipsen, showing significant efficacy and safety profile improvements

GENFIT EASL Congress Elafibranor Phase 2 Data Primary Sclerosing Cholangitis
PRESS RELEASE

published on 04/28/2025 at 22:10, 7 months 6 days ago

GENFIT : les données positives de la Phase 2 évaluant elafibranor dans la Cholangite Sclérosante Primitive (PSC) seront présentées en « late breaking » par Ipsen au congrès de l'EASL 2025
GENFIT annonce les résultats positifs de la Phase 2 sur elafibranor dans la Cholangite Sclérosante Primitive (PSC) à l'EASL 2025

GENFIT Maladies Rares Du Foie Elafibranor Cholangite Sclérosante Primitive EASL 2025
PRESS RELEASE

published on 04/24/2025 at 22:10, 7 months 10 days ago

GENFIT : Résultats financiers annuels 2024 et point sur les activités de la Société

Accesswire

Published on 12/05/2025 at 17:15, 47 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 2 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 2 hours 2 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 2 hours 17 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 2 hours 17 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 17:51, 11 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 16 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 2 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 37 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 52 minutes ago

Reorganization of the Eckert & Ziegler Executive Board

Les Echos

Published on 12/05/2025 at 17:18, 44 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 44 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 52 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 52 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 4 hours 4 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE